Related Experiment Video

Updated: May 24, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.4K

STK31 drives tumor immune evasion through STAT3-IL-6 mediated CD8+ T cell exhaustion

Shasha Li1,2, Jiaming Lin1, Liu Huang3

  • 1Department of Human Anatomy, Histology and Embryology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Oncogene
|March 2, 2025
PubMed

Insights

Serine/threonine kinase 31 (STK31) drives non-small cell lung cancer (NSCLC) growth and immune evasion by activating STAT3 signaling. STK31 is a potential therapeutic target for NSCLC patients.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Protein kinase dysregulation is implicated in non-small cell lung cancer (NSCLC) initiation, progression, and drug resistance.
  • Identifying novel oncogenic drivers is critical for developing targeted therapies in NSCLC.

Purpose of the Study:

  • To identify and functionally characterize novel dysregulated genes in NSCLC.
  • To investigate the role of Serine/threonine kinase 31 (STK31) in NSCLC pathogenesis and immune escape.

Main Methods:

  • Comprehensive analysis of TCGA database and literature.
  • Functional studies in immune-competent and nude mice models.
  • Investigation of STK31's mechanism involving CD8+ T cells, STAT3, and IL-6 signaling.

Main Results:

  • STK31 was identified as a frequently dysregulated gene in NSCLC.
  • Upregulation of STK31 promoted tumor growth and CD8+ T cell exhaustion in vivo.
  • STK31 activates the STAT3-IL-6 pathway, facilitating immune escape.
  • Elevated STK31 expression correlates with poor prognosis in NSCLC patients.

Conclusions:

  • STK31 plays a critical role in promoting NSCLC immune escape via STAT3 activation.
  • STK31 represents a promising therapeutic target for NSCLC treatment.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

557

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K